Skip to content

Study · In vitro (cells) · 2006

1 result

Thymosin beta10 inhibits cell migration and capillary-like tube formation of human coronary artery endothelial cells.

Mu H, Ohashi R, Yang H, Wang X, Li M, Lin P, Yao Q, Chen C

Cell motility and the cytoskeleton1 Apr 2006Cited by 24 (Europe PMC)

PMID16496302 (opens in a new tab)DOI10.1002/cm.20117 (opens in a new tab)PepBankPUB-16496302
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    In human coronary artery endothelial cells, thymosin beta4 significantly increased cell migration.

    In plain wordsIn cells, thymosin beta4 increased migration of human coronary artery endothelial cells.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseHCAEC migration with thymosin beta4
    Study

    humann: not reported in source

    human coronary artery endothelial cells (HCAECs)
    Outcome group
    Wound healing · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    By contrast, thymosin beta4 significantly increased HCAEC migration.
    1 context sentence
    Summary · context
    To determine the direct effects of exogenous thymosin beta10 on angiogenic potentials as endothelial cell migration and capillary-like tube formation, human coronary artery endothelial cells (HCAECs) were incubated with increasing doses of thymosin beta10 (25-100 ng/ml).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.